Can money skills and peer support help teens beat HIV? new study tests four tools together.

NCT ID NCT05600621

Ongoing Disease control Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests four different support tools—financial literacy training, matched savings accounts, a cartoon-based adherence guide, and role models with HIV—to see which combination best helps youth aged 11-17 in Uganda stay on their HIV medication and keep the virus undetectable. About 576 adolescents from 48 clinics will be assigned to different combinations of these tools and followed for three years. The goal is to find the most effective and affordable way to improve long-term viral suppression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Financial literacy training, matched savings accounts, adherence cartoon, and role model engagement
What this could lead to: If successful, this could identify a cost-effective combination of behavioral and economic supports to help youth with HIV stay on treatment and achieve long-term viral suppression.
What could go wrong: This is a behavioral intervention study, not a drug trial, so results may vary by setting. The 3-year follow-up is long, but adherence may still drop after the study ends.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

International Center for Child Health and Development

Masaka, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.